Uncategorized
Glaukos Announces Participation in William Blair Growth Stock Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2019, at 8:00 a.m. CDT in Chicago, IL. A live audio webcast for this eve